Cancer stem cells and therapeutic targets

An emerging field for cancer treatment

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Recent paradigm in the field of cancer defines its origin from a small population of fast-growing cells known as cancer stem cells (CSCs), and they are mainly responsible for disease aggressiveness, drug resistance, and tumor relapse. The existence of CSCs has been proven in different types of cancer and possesses characteristic expression of a wide array of cell surface markers specific to the type of cancer. CSCs have been isolated and enriched using several surface markers in different cancer types. Self-renewal, drug resistance, and the ability to transition from epithelial to mesenchymal phenotype are the major features attributed to this fraction of mutated stem cells. The CSC hypothesis proposes that these CSCs mimic stem cells by sharing similar pathways, such as Wnt, SHH, Notch, and others. Further, the niche, which in this case is the tumor microenvironment, plays a very important role in the maintenance of CSCs. Altogether, this emerging field of research on CSCs is expected to unveil answers to the most difficult issues of one of the most dreadful diseases called cancer.

Original languageEnglish (US)
Pages (from-to)113-120
Number of pages8
JournalDrug Delivery and Translational Research
Volume3
Issue number2
DOIs
StatePublished - Mar 14 2013

Fingerprint

Neoplastic Stem Cells
Neoplasms
Drug Resistance
Therapeutics
Stem Cells
Epithelial-Mesenchymal Transition
Tumor Microenvironment
Maintenance
Phenotype
Recurrence
Research
Population

Keywords

  • CSC markers
  • Cancer stem cells
  • Drug resistance
  • Therapy targets

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Cancer stem cells and therapeutic targets : An emerging field for cancer treatment. / Vaz, Arokia Priyanka; Palanimuthu Ponnusamy, Moorthy; Batra, Surinder Kumar.

In: Drug Delivery and Translational Research, Vol. 3, No. 2, 14.03.2013, p. 113-120.

Research output: Contribution to journalReview article

@article{3ea920ddd6dc42c6b248b8c566f26c3b,
title = "Cancer stem cells and therapeutic targets: An emerging field for cancer treatment",
abstract = "Recent paradigm in the field of cancer defines its origin from a small population of fast-growing cells known as cancer stem cells (CSCs), and they are mainly responsible for disease aggressiveness, drug resistance, and tumor relapse. The existence of CSCs has been proven in different types of cancer and possesses characteristic expression of a wide array of cell surface markers specific to the type of cancer. CSCs have been isolated and enriched using several surface markers in different cancer types. Self-renewal, drug resistance, and the ability to transition from epithelial to mesenchymal phenotype are the major features attributed to this fraction of mutated stem cells. The CSC hypothesis proposes that these CSCs mimic stem cells by sharing similar pathways, such as Wnt, SHH, Notch, and others. Further, the niche, which in this case is the tumor microenvironment, plays a very important role in the maintenance of CSCs. Altogether, this emerging field of research on CSCs is expected to unveil answers to the most difficult issues of one of the most dreadful diseases called cancer.",
keywords = "CSC markers, Cancer stem cells, Drug resistance, Therapy targets",
author = "Vaz, {Arokia Priyanka} and {Palanimuthu Ponnusamy}, Moorthy and Batra, {Surinder Kumar}",
year = "2013",
month = "3",
day = "14",
doi = "10.1007/s13346-012-0095-x",
language = "English (US)",
volume = "3",
pages = "113--120",
journal = "Drug Delivery and Translational Research",
issn = "2190-393X",
publisher = "Springer Publishing Company",
number = "2",

}

TY - JOUR

T1 - Cancer stem cells and therapeutic targets

T2 - An emerging field for cancer treatment

AU - Vaz, Arokia Priyanka

AU - Palanimuthu Ponnusamy, Moorthy

AU - Batra, Surinder Kumar

PY - 2013/3/14

Y1 - 2013/3/14

N2 - Recent paradigm in the field of cancer defines its origin from a small population of fast-growing cells known as cancer stem cells (CSCs), and they are mainly responsible for disease aggressiveness, drug resistance, and tumor relapse. The existence of CSCs has been proven in different types of cancer and possesses characteristic expression of a wide array of cell surface markers specific to the type of cancer. CSCs have been isolated and enriched using several surface markers in different cancer types. Self-renewal, drug resistance, and the ability to transition from epithelial to mesenchymal phenotype are the major features attributed to this fraction of mutated stem cells. The CSC hypothesis proposes that these CSCs mimic stem cells by sharing similar pathways, such as Wnt, SHH, Notch, and others. Further, the niche, which in this case is the tumor microenvironment, plays a very important role in the maintenance of CSCs. Altogether, this emerging field of research on CSCs is expected to unveil answers to the most difficult issues of one of the most dreadful diseases called cancer.

AB - Recent paradigm in the field of cancer defines its origin from a small population of fast-growing cells known as cancer stem cells (CSCs), and they are mainly responsible for disease aggressiveness, drug resistance, and tumor relapse. The existence of CSCs has been proven in different types of cancer and possesses characteristic expression of a wide array of cell surface markers specific to the type of cancer. CSCs have been isolated and enriched using several surface markers in different cancer types. Self-renewal, drug resistance, and the ability to transition from epithelial to mesenchymal phenotype are the major features attributed to this fraction of mutated stem cells. The CSC hypothesis proposes that these CSCs mimic stem cells by sharing similar pathways, such as Wnt, SHH, Notch, and others. Further, the niche, which in this case is the tumor microenvironment, plays a very important role in the maintenance of CSCs. Altogether, this emerging field of research on CSCs is expected to unveil answers to the most difficult issues of one of the most dreadful diseases called cancer.

KW - CSC markers

KW - Cancer stem cells

KW - Drug resistance

KW - Therapy targets

UR - http://www.scopus.com/inward/record.url?scp=84874807742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874807742&partnerID=8YFLogxK

U2 - 10.1007/s13346-012-0095-x

DO - 10.1007/s13346-012-0095-x

M3 - Review article

VL - 3

SP - 113

EP - 120

JO - Drug Delivery and Translational Research

JF - Drug Delivery and Translational Research

SN - 2190-393X

IS - 2

ER -